MedPath

CYRANO THERAPEUTICS, INC.

CYRANO THERAPEUTICS, INC. logo
🇺🇸United States
Ownership
Holding
Established
2014-01-01
Employees
1
Market Cap
-
Website
http://www.cyranotherapeutics.com

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Study of CYR-064 Versus Placebo in Patients.

Phase 2
Active, not recruiting
Conditions
Hyposmia
First Posted Date
2023-08-31
Last Posted Date
2025-04-27
Lead Sponsor
Cyrano Therapeutics, Inc.
Target Recruit Count
150
Registration Number
NCT06019000
Locations
🇺🇸

Colorado ENT & Allergy, Colorado Springs, Colorado, United States

🇺🇸

ENTAAFL, Port Saint Lucie, Florida, United States

🇺🇸

Rush University Medical Center, Chicago, Illinois, United States

and more 9 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.